- Report
- March 2020
- 40 Pages
Brazil
From €2490EUR$2,595USD£2,153GBP
- Report
- March 2020
- 40 Pages
Russia
From €2490EUR$2,595USD£2,153GBP
- Report
- March 2020
- 40 Pages
South Korea
From €2490EUR$2,595USD£2,153GBP
- Report
- March 2020
- 40 Pages
Japan
From €2490EUR$2,595USD£2,153GBP
- Report
- March 2020
- 80 Pages
Africa
From €3641EUR$3,795USD£3,149GBP
- Book
- October 2012
- 1570 Pages
The Malaria Vaccine market is a subset of the larger Vaccines market. It is focused on the development and distribution of vaccines to prevent and treat malaria, a mosquito-borne infectious disease that affects millions of people worldwide. Vaccines are the most effective way to prevent malaria, and the market is driven by the need to reduce the burden of the disease.
The Malaria Vaccine market is composed of a variety of stakeholders, including pharmaceutical companies, research institutions, and public health organizations. These stakeholders collaborate to develop and distribute vaccines to those in need. Vaccines are typically administered through injection or oral administration, and are often combined with other preventative measures such as insecticide-treated bed nets and indoor residual spraying.
The Malaria Vaccine market is highly competitive, with a number of companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Sanofi, Merck, and Pfizer. Show Less Read more